WHO Drug Information Vol. 24, No. 4, 2010

WHO Drug Information, Vol. 24, No. 4, 2010 Proposed INN: List 104909875-08-7Heavy chain / Chaîne lourde / Cadena pesadaQVQLVQSGAE VKKPGSSVKV SCKASGGTFS YYWIEWVRQA PGQGLEWMGE 50ILPGSGTTNP NEKFKGRVTI TADESTSTAY MELSSLRSED TAVYYCARAD 100YYGSDYVKFD YWGQGTLVTV SSASTKGPSV FPLAPSSKST SGGTAALGCL 150VKDYFPEPVT VSWNSGALTS GVHTFPAVLQ SSGLYSLSSV VTVPSSSLGT 200QTYICNVNHK PSNTKVDKRV EPKSCDKTHT CPPCPAPELL GGPSVFLFPP 250KPKDTLMISR TPEVTCVVVD VSHEDPEVKF NWYVDGVEVH NAKTKPREEQ 300YNSTYRVVSV LTVLHQDWLN GKEYKCKVSN KALPAPIEKT ISKAKGQPRE 350PQVYTLPPSR EEMTKNQVSL TCLVKGFYPS DIAVEWESNG QPENNYKTTP 400PVLDSDGSFF LYSKLTVDKS RWQQGNVFSC SVMHEALHNH YTQKSLSLSP 450GK 452Light chain / Chaîne légère / Cadena ligeraDIQMTQSPSS LSASVGDRVT ITCKASQHVI THVTWYQQKP GKAPKLLIYG 50TSYSYSGVPS RFSGSGSGTD FTLTISSLQP EDFATYYCQQ FYEYPLTFGG 100GTKVEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV 150DNALQSGNSQ ESVTEQDSKD STYSLSSTLT LSKADYEKHK VYACEVTHQG 200LSSPVTKSFN RGEC 214Disulfide bridges location / Position des ponts disulfure / Posiciones de los puentes disulfuroIntra-H 22-96 149-205 266-326 372-43022''-96'' 149''-205'' 266''-326'' 372''-430''Intra-L 23'-88' 134'-194'23'''-88''' 134'''-194'''Inter-H-L 225-214' 225''-214'''Inter-H-H 231-231'' 234-234''N-glycosylation sites / Sites de N-glycosylation / Posiciones de N-glicosilación302, 302''erismodegibumerismodegibérismodégiberismodegibN-{6-[(2R,6S)-2,6-dimethylmorpholin-4-yl]pyridin-3-yl}-2-methyl-4'-(trifluoromethoxy)-[1,1'-biphenyl]-3-carboxamideantineoplasticN-{6-[(2R,6S)-2,6-diméthylmorpholin-4-yl]pyridin-3-yl}-2-méthyl-4'-(trifluorométhoxy)-[1,1'-biphényl]-3-carboxamideantinéoplasiqueN-{6-[(2R,6S)-2,6-dimetilmorfolin-4-il]piridin-3-il}-2-metil-4'-(trifluorometoxi)-[1,1'-bifenil]-3-carboxamidaantineoplásicoC 26 H 26 F 3 N 3 O 3 956697-53-3HCH 3OF 3 COCH 3ONHNNCH 3Herteberelumerteberelertébérel(3aS,4R,9bR)-4-(4-hydroxyphenyl)-1,2,3,3a,4,9bhexahydrocyclopenta[c]chromen-8-olbeta estrogen receptor agonist(3aS,4R,9bR)-4(4-hydroxyphényl)-1,2,3,3a,4,9bhexahydrocyclopenta[c][1]chromén-8-olagoniste des récepteurs oestrogéniques beta369